These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 23741527

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Molecular dynamics studies of the inhibitor C34 binding to the wild-type and mutant HIV-1 gp41: inhibitory and drug resistant mechanism.
    Ma X, Tan J, Su M, Li C, Zhang X, Wang C.
    PLoS One; 2014; 9(11):e111923. PubMed ID: 25393106
    [Abstract] [Full Text] [Related]

  • 26. The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance.
    Chong H, Yao X, Qiu Z, Sun J, Qiao Y, Zhang M, Wang M, Cui S, He Y.
    J Antimicrob Chemother; 2014 Oct; 69(10):2759-69. PubMed ID: 24908047
    [Abstract] [Full Text] [Related]

  • 27. Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.
    Lai W, Wang C, Yan J, Liu H, Zhang W, Lin B, Xi Z.
    Bioorg Med Chem; 2020 Feb 15; 28(4):115214. PubMed ID: 31932193
    [Abstract] [Full Text] [Related]

  • 28. Adding an Artificial Tail-Anchor to a Peptide-Based HIV-1 Fusion Inhibitor for Improvement of Its Potency and Resistance Profile.
    Su S, Ma Z, Hua C, Li W, Lu L, Jiang S.
    Molecules; 2017 Nov 20; 22(11):. PubMed ID: 29156603
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.
    Miyauchi K, Kozlov MM, Melikyan GB.
    PLoS Pathog; 2009 Sep 20; 5(9):e1000585. PubMed ID: 19763181
    [Abstract] [Full Text] [Related]

  • 31. HIV-1 gp41 fusion intermediate: a target for HIV therapeutics.
    Pan C, Liu S, Jiang S.
    J Formos Med Assoc; 2010 Feb 20; 109(2):94-105. PubMed ID: 20206833
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry.
    Wang X, Xiong W, Ma X, Wei M, Chen Y, Lu L, Debnath AK, Jiang S, Pan C.
    PLoS One; 2012 Feb 20; 7(9):e44874. PubMed ID: 22970321
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A multi-functional peptide as an HIV-1 entry inhibitor based on self-concentration, recognition, and covalent attachment.
    Zhao L, Tong P, Chen YX, Hu ZW, Wang K, Zhang YN, Zhao DS, Cai LF, Liu KL, Zhao YF, Li YM.
    Org Biomol Chem; 2012 Aug 28; 10(32):6512-20. PubMed ID: 22760295
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41.
    Gustchina E, Louis JM, Bewley CA, Clore GM.
    J Mol Biol; 2006 Dec 01; 364(3):283-9. PubMed ID: 17010381
    [Abstract] [Full Text] [Related]

  • 38. ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formation.
    Wang H, Qi Z, Guo A, Mao Q, Lu H, An X, Xia C, Li X, Debnath AK, Wu S, Liu S, Jiang S.
    Antimicrob Agents Chemother; 2009 Dec 01; 53(12):4987-98. PubMed ID: 19786602
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A, Biron Z, Arshava B, Scherf T, Naider F, Anglister J.
    FEBS J; 2015 Dec 01; 282(24):4643-57. PubMed ID: 26432362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.